"10.1371_journal.pone.0086273","plos one","2014-01-28T00:00:00Z","Zhen Liu; Franck Lebrin; Janita A Maring; Sander van den Driesche; Stieneke van der Brink; Maarten van Dinther; Midory Thorikay; Sabrina Martin; Kazuki Kobayashi; Lukas J A C Hawinkels; Laurens A van Meeteren; Evangelia Pardali; Jeroen Korving; Michelle Letarte; Helen M Arthur; Charles Theuer; Marie-José Goumans; Christine Mummery; Peter ten Dijke","Department of Molecular Cell Biology, Cancer Genomics Centre, Centre for Biomedical Genetics, Leiden University Medical Center, Leiden, The Netherlands; Hubrecht Institute, Utrecht, The Netherlands; Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, The Netherlands; Center for Interdisciplinary Research in Biology (CIRB), CNRS UMR 7241/INSERM U1050, Collège de France, Paris, France; Molecular Structure and Function Program, The Hospital of Sick Children, Department of Immunology and Heart and Stroke Richard Lewar Center of Excellence, University of Toronto, Toronto, Ontario, Canada; Institute of Genetic Medicine, Newcastle University, International Centre for Life, Newcastle upon Tyne, United Kingdom; Tracon Pharmaceuticals, San Diego, California, United States of America","Conceived and designed the experiments: ZL FL JM SvdD MJG CM PtD. Performed the experiments: ZL FL JM SvdD SvdB MvD MT JK SM. Analyzed the data: ZL FL JM SvdD MJG CM PtD LJACH LvM EP. Contributed reagents/materials/analysis tools: KK ML HMA CT. Wrote the paper: ZL FL JM SvdD MJG CM PtD.","Charles Theuer is employed by Tracon Pharmaceuticals that is developing TRC105 for anti-angiogenesis therapy to treat cancer patients. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. All other authors have declared that no competing interest exists.","2014","01","Zhen Liu","ZL",19,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
